Put CV Risks With Triptans in Perspective
December 2022
We’re getting questions about which patients should avoid triptans due to cardiovascular concerns.
Labelling says that triptans shouldn’t be used in patients with coronary artery disease, stroke, uncontrolled hypertension, etc.
This stems from the early 1990s when it was thought that heart attacks were caused by vasospasm. Patients with CV disease or uncontrolled hypertension were excluded from triptan trials.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive